LIFS — Life Stem Genetics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- -$0.00m
Annual cashflow statement for Life Stem Genetics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2012 July 31st | 2013 July 31st | |
|---|---|---|
| Period Length: | 1 M | 12 M |
| Source: | PROSPECTUS | 10-K |
| Standards: | — | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0 | -0.039 |
| Depreciation | ||
| Cash from Operating Activities | -0 | -0.039 |
| Capital Expenditures | — | -0 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | — | -0 |
| Financing Cash Flow Items | 0.004 | 0.018 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0.008 | 0.031 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.008 | -0.008 |